MGAM and viral infectious disease: Our data showed that, similarly with NTAN1WT, the MG-132 treatment dramatically enhanced the protein level of exogenously expressed NTAN1K40A, NTAN1K63A or NTAN1K134A in the absence of viral infection (Figure 6—figure supplement 2B,C and D, lanes 1 vs. 4).